We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$951M
AUM Growth
+$133M
Cap. Flow
-$12.4M
Cap. Flow %
-1.31%
Top 10 Hldgs %
47%
Holding
249
New
31
Increased
43
Reduced
87
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 18.46%
3 Financials 16.05%
4 Consumer Discretionary 15.98%
5 Communication Services 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTC icon
51
PTC
PTC
$15.3B
$2.81M 0.3%
+36,130
New +$2.56M
CMD
52
DELISTED
Cantel Medical Corporation
CMD
$2.75M 0.29%
62,186
+56,284
+954% +$2.1M
VTI icon
53
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$2.45M 0.26%
15,679
+108
+0.7% +$15.9K
UNH icon
54
UnitedHealth
UNH
$382B
$2.32M 0.24%
7,854
-2,000
-20% -$573K
CIT
55
DELISTED
CIT Group Inc.
CIT
$2.21M 0.23%
106,724
-13,458
-11% -$260K
ORLY icon
56
O'Reilly Automotive
ORLY
$75.1B
$2.01M 0.21%
71,625
-645
-0.9% -$16.9K
IWB icon
57
iShares Russell 1000 ETF
IWB
$47.1B
$1.99M 0.21%
11,589
+5,921
+104% +$958K
MRK icon
58
Merck
MRK
$322B
$1.93M 0.2%
26,161
+21
+0.1% +$1.58K
PG icon
59
Procter & Gamble
PG
$340B
$1.91M 0.2%
15,935
T icon
60
AT&T
T
$164B
$1.91M 0.2%
83,442
-23
-0% -$524
CCI icon
61
Crown Castle
CCI
$34.6B
$1.82M 0.19%
10,875
PGR icon
62
Progressive
PGR
$128B
$1.81M 0.19%
22,655
-21,448
-49% -$1.67M
IBB icon
63
iShares Biotechnology ETF
IBB
$9.45B
$1.72M 0.18%
12,567
+58
+0.5% +$7.39K
MRSH
64
Marsh
MRSH
$94.3B
$1.69M 0.18%
15,717
+3,242
+26% +$328K
NOC icon
65
Northrop Grumman
NOC
$76B
$1.68M 0.18%
5,478
+173
+3% +$56.7K
CHKP icon
66
Check Point Software Technologies
CHKP
$14.3B
$1.64M 0.17%
+15,220
New +$1.61M
ADP icon
67
Automatic Data Processing
ADP
$109B
$1.61M 0.17%
10,834
SEDG icon
68
SolarEdge
SEDG
$2.37B
$1.61M 0.17%
11,600
KMI icon
69
Kinder Morgan
KMI
$70.9B
$1.54M 0.16%
101,618
SBUX icon
70
Starbucks
SBUX
$119B
$1.49M 0.16%
20,249
-100
-0.5% -$7.51K
AXS icon
71
AXIS Capital
AXS
$7.73B
$1.43M 0.15%
35,351
TRMB icon
72
Trimble
TRMB
$13.6B
$1.43M 0.15%
33,000
BIIB icon
73
Biogen
BIIB
$30.9B
$1.41M 0.15%
5,280
BRK.A icon
74
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.34M 0.14%
5
CVS icon
75
CVS Health
CVS
$135B
$1.24M 0.13%
19,019
+56
+0.3% +$3.53K

Similar funds

Cannell & Spears's Q2 2020 Portfolio in Review

As of Q2 2020, Cannell & Spears held 249 positions worth $951M, up 16% from $817M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cannell & Spears's Q2 2020 filing shows 31 new, 43 increased, 87 reduced and 23 closed positions. Its largest new stake was Berry Global Group, Inc.: 351,503 shares worth $14.3M. The largest sale was Delta Air Lines, an estimated $14.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Cannell & Spears's largest Q2 2020 buy was Berry Global Group, Inc.: 351,503 shares worth $14.3M.
  • Cannell & Spears added most to Intercontinental Exchange in Q2 2020, an estimated $14.1M increase.
  • Cannell & Spears's biggest Q2 2020 reduction was Thermo Fisher Scientific, cutting an estimated $13.8M.
  • Cannell & Spears fully exited Delta Air Lines in Q2 2020, selling an estimated $14.9M.
  • Cannell & Spears's ten largest holdings make up 47% of its $951M portfolio in Q2 2020.
  • Cannell & Spears opened 31 new positions and closed 23 in Q2 2020.
  • Cannell & Spears's portfolio value rose 16% quarter-over-quarter to $951M.

Based on Cannell & Spears's 13F filing for Q2 2020, filed 12 Aug 2020.